Kyle Denton

Kyle Denton

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in SLAS Discovery
Verified
Journal Article
Open access
PDF file
KDKyle Denton
Kyle Denton
SWSijie Wang
Sijie Wang
MGMichael C. Gignac
Michael C. Gignac
NMNatalia Milosevich
Natalia Milosevich
FHFraser Hof
Fraser Hof
CKCasey Krusemark
Casey Krusemark
The identification of protein ligands from a DNA-encoded library is commonly conducted by an affinity selection assay. These assays are often not validated for robustness, raising questions about selections that fail to identify ligands and the utility of enrichment values for ranking ligand potencies. Here, we report a method for optimizing and utilizing affinity selection assays to identify potent and selective peptidic ligands to the highly related chromodomains of CBX proteins. To optimize affinity selection parameters, statistical analyses (Z′ factors) were used to define the ability of selection assay conditions to identify and differentiate ligands of varying affinity. A DNA-encoded positional scanning library of peptidomimetics was constructed around a trimethyllysine-containing parent peptide, and parallel selections against the chromodomains from CBX8 and CBX7 were conducted over three protein concentrations. Relative potencies of off-DNA hit molecules were determined through a fluorescence polarization assay and were consistent with enrichments observed by DNA sequencing of the affinity selection assays. In addition, novel peptide-based ligands were discovered with increased potency and selectivity to the chromodomain of CBX8. The results indicate low DNA tag bias and show that affinity-based in vitro selection assays are sufficiently robust for both ligand discovery and determination of quantitative structure–activity relationships.

30 July 2019 in Molecules
Verified
Journal Article
Open access
PDF file
DKDongwook Kim
Dongwook Kim
YSYixing Sun
Yixing Sun
DXDan Xie
Dan Xie
KDKyle Denton
Kyle Denton
HCHao Chen
Hao Chen
CKCasey Krusemark
Casey Krusemark
As aberrant activity of protein kinases is observed in many disease states, these enzymes are common targets for therapeutics and detection of activity levels. The development of non-natural protein kinase substrates offers an approach to protein substrate competitive inhibitors, a class of kinase inhibitors with promise for improved specificity. Also, kinase activity detection approaches would benefit from substrates with improved activity and specificity. Here, we apply a substrate-mediated selection to a peptidomimetic DNA-encoded chemical library for enrichment of molecules that can be phosphorylated by the protein tyrosine kinase, c-Src. Several substrates were identified and characterized for activity. A lead compound (SrcDEL10) showed both the ability to serve as a substrate and to promote ATP hydrolysis by the kinase. In inhibition assays, compounds displayed IC50′s ranging from of 8–100 µM. NMR analysis of SrcDEL10 bound to the c-Src:ATP complex was conducted to characterize the binding mode. An ester derivative of the lead compound demonstrated cellular activity with inhibition of Src-dependent signaling in cell culture. Together, the results show the potential for substrate-mediated selections of DNA-encoded libraries to discover molecules with functions other than simple protein binding and offer a new discovery method for development of synthetic tyrosine kinase substrates.

20 May 2024 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
SLSimon C. C. Lucas
Simon C. C. Lucas
JBJ. Henry Blackwell
J. Henry Blackwell
UBUlf Börjesson
Ulf Börjesson
DHDavid Hargreaves
David Hargreaves
AMAlexander G. Milbradt
Alexander G. Milbradt
EREmma L. Rivers
Emma L. Rivers